US 11,432,808

Application 16/846,445 · Granted Sep 6, 2022

Guide wire

Estimated expiration

October 14, 2038

11y 329d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTJP2017037001: Resource not found (404)
Earliest effective filing
Oct 12, 2017
+ 20 years
Oct 12, 2037
PTA +367d
Oct 14, 2038
No TD
—
Final
Oct 14, 2038

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
April 13, 2020
Earliest effective filing
October 12, 2017
Issue date
September 6, 2022
PTA
+367 days
Base expiry (before PTA)
October 12, 2037

October 12, 2017 + 20 years = October 12, 2037 + 367 PTA days = October 14, 2038

  • Continuation of application PCTJP2017037001, filed Oct 12, 2017

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 16/846,445 · US 11,432,808

PatentReply compiles the prosecution history behind US 11,432,808: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11432808

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.